Endometrial Stromal Sarcomas
1 clinical trials · Condition
◉ Watch Endometrial Stromal Sarcomas
| Record | Firm | Date |
|---|---|---|
| Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 (NCT02150213) | Novartis Pharmaceuticals | 2014-08-01 |
Track Endometrial Stromal Sarcomas automatically
Every clearance here is in the API, with alerts when new ones post.